European Commission (CE) Mark 0068/QCO-DM/337-2021 Certified
iHealthScreen ISO 13485:2016 Certified
USA HIPAA Compliance Certified
Accenture Certified. Accenture Audited and Passed
The First prediction model for Late AMD; featured work at ARVO 2018/Macular News
Won 3 Prestigious National Institute of Health (NIH) Research grant @ $2.5M.
Accepted START-UP New York Program (a highly competitive program and 10 years tax-free business in NY state)
Finalist of ‘StartUP competition’ at Medtech, Nuremberg, Germany 2019 (top 10 among 131 companies, from all continents)
2 patents (pending) and 4 patent applications submitted
The best prediction model for stroke and Heart Disease prediction
Published the AMD, DR and Glaucoma screening results at top medical journals (Diabetes Care, TVST and IOVS).
Completed Acc2EU Program
iHealthScreen was Finalist at MedTec 2019, Nuremberg, Germany and accepted for Medical Valley Incubation Program.
Abu Dhabi Global Market (ADGM) Registered Company